Targeting Skin Neoplasms: A Review of Berberine’s Anticancer Properties

Skin cancers are associated with a significant psychological burden across all age groups, particularly as their global incidence continues to rise. Ultraviolet (UV) radiation—primarily UVA and UVB—remains the leading etiological factor, inducing DNA mutations in key genes such as TP53 and BRAF. Amo...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna Duda-Madej, Patrycja Lipska, Szymon Viscardi, Hanna Bazan, Jakub Sobieraj
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/14/14/1041
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849406768811081728
author Anna Duda-Madej
Patrycja Lipska
Szymon Viscardi
Hanna Bazan
Jakub Sobieraj
author_facet Anna Duda-Madej
Patrycja Lipska
Szymon Viscardi
Hanna Bazan
Jakub Sobieraj
author_sort Anna Duda-Madej
collection DOAJ
description Skin cancers are associated with a significant psychological burden across all age groups, particularly as their global incidence continues to rise. Ultraviolet (UV) radiation—primarily UVA and UVB—remains the leading etiological factor, inducing DNA mutations in key genes such as TP53 and BRAF. Among skin cancers, basal cell carcinoma (BCC) is the most prevalent and typically indolent. In contrast, squamous cell carcinoma (SCC) tends to be more invasive, while melanoma is the most aggressive and prone to metastasis. Melanoma is especially concerning due to its rapid dissemination and its occurrence not only on the skin but also in ocular, mucosal, and nail tissues. These challenges, along with rising treatment resistance and mortality, underscore the urgent need for novel anticancer agents. Berberine—a plant-derived isoquinoline alkaloid—has attracted increasing attention for its broad-spectrum anticancer potential, including against skin cancers. In this review, we summarize current evidence regarding berberine’s mechanisms of action in melanoma and SCC, emphasizing both its preventive and therapeutic effects. We further explore its potential as an adjuvant agent in combination with conventional treatments, offering a promising avenue for enhancing the clinical outcomes of skin cancer therapy.
format Article
id doaj-art-3105b2ad5da14d98a6ed24fc99055cc4
institution Kabale University
issn 2073-4409
language English
publishDate 2025-07-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj-art-3105b2ad5da14d98a6ed24fc99055cc42025-08-20T03:36:17ZengMDPI AGCells2073-44092025-07-011414104110.3390/cells14141041Targeting Skin Neoplasms: A Review of Berberine’s Anticancer PropertiesAnna Duda-Madej0Patrycja Lipska1Szymon Viscardi2Hanna Bazan3Jakub Sobieraj4Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, Chałubińskiego 4, 50-368 Wrocław, PolandFaculty of Medicine, Wroclaw Medical University, Ludwika Pasteura 1, 50-367 Wrocław, PolandFaculty of Medicine, Wroclaw Medical University, Ludwika Pasteura 1, 50-367 Wrocław, PolandFaculty of Medicine, Wroclaw Medical University, Ludwika Pasteura 1, 50-367 Wrocław, PolandFaculty of Medicine, Wroclaw Medical University, Ludwika Pasteura 1, 50-367 Wrocław, PolandSkin cancers are associated with a significant psychological burden across all age groups, particularly as their global incidence continues to rise. Ultraviolet (UV) radiation—primarily UVA and UVB—remains the leading etiological factor, inducing DNA mutations in key genes such as TP53 and BRAF. Among skin cancers, basal cell carcinoma (BCC) is the most prevalent and typically indolent. In contrast, squamous cell carcinoma (SCC) tends to be more invasive, while melanoma is the most aggressive and prone to metastasis. Melanoma is especially concerning due to its rapid dissemination and its occurrence not only on the skin but also in ocular, mucosal, and nail tissues. These challenges, along with rising treatment resistance and mortality, underscore the urgent need for novel anticancer agents. Berberine—a plant-derived isoquinoline alkaloid—has attracted increasing attention for its broad-spectrum anticancer potential, including against skin cancers. In this review, we summarize current evidence regarding berberine’s mechanisms of action in melanoma and SCC, emphasizing both its preventive and therapeutic effects. We further explore its potential as an adjuvant agent in combination with conventional treatments, offering a promising avenue for enhancing the clinical outcomes of skin cancer therapy.https://www.mdpi.com/2073-4409/14/14/1041anticancer activityberberinemelanomaskin neoplasmssquamous cell carcinomanatural compounds
spellingShingle Anna Duda-Madej
Patrycja Lipska
Szymon Viscardi
Hanna Bazan
Jakub Sobieraj
Targeting Skin Neoplasms: A Review of Berberine’s Anticancer Properties
Cells
anticancer activity
berberine
melanoma
skin neoplasms
squamous cell carcinoma
natural compounds
title Targeting Skin Neoplasms: A Review of Berberine’s Anticancer Properties
title_full Targeting Skin Neoplasms: A Review of Berberine’s Anticancer Properties
title_fullStr Targeting Skin Neoplasms: A Review of Berberine’s Anticancer Properties
title_full_unstemmed Targeting Skin Neoplasms: A Review of Berberine’s Anticancer Properties
title_short Targeting Skin Neoplasms: A Review of Berberine’s Anticancer Properties
title_sort targeting skin neoplasms a review of berberine s anticancer properties
topic anticancer activity
berberine
melanoma
skin neoplasms
squamous cell carcinoma
natural compounds
url https://www.mdpi.com/2073-4409/14/14/1041
work_keys_str_mv AT annadudamadej targetingskinneoplasmsareviewofberberinesanticancerproperties
AT patrycjalipska targetingskinneoplasmsareviewofberberinesanticancerproperties
AT szymonviscardi targetingskinneoplasmsareviewofberberinesanticancerproperties
AT hannabazan targetingskinneoplasmsareviewofberberinesanticancerproperties
AT jakubsobieraj targetingskinneoplasmsareviewofberberinesanticancerproperties